约翰斯疾病诊断市场机会、成长驱动因素、产业趋势分析与预测 2024 - 2032 年

到 2023 年，全球约翰氏症诊断市场价值将达到 6.456 亿美元，预计在预测期内复合年增长率为 5.2%。这种增长主要归因于人们对约翰氏症及其对牲畜健康和生产力影响的认识不断提高。约翰斯病是由鸟分枝桿菌副结核亚种 (MAP) 引起，是一种影响牛、绵羊和山羊的慢性胃肠道感染。随着畜牧生产者越来越意识到这种疾病的经济影响，对有效诊断解决方案的需求正在增加。

最近的统计数据强调了约翰氏症的广泛流行及其对畜牧业的重大经济影响，并强调了对先进诊断方法的需求。 PCR 和血清学检测等诊断技术的进步显着提高了检测的准确性和速度。这些改进使诊断技术对兽医和牲畜所有者更具吸引力。此外，对动物福利和永续农业实践的重视进一步推动了采用可靠的诊断方法来有效识别和管理受感染的牲畜。

这些因素共同促进了约翰氏症诊断市场的正向成长轨迹。约翰斯病诊断采用多种方法来检测 MAP，包括识别抗体的酶联免疫吸附测定 (ELISA) 和检测粪便样本中的 MAP DNA 的聚合酶链反应 (PCR) 测试。早期准确的诊断对于控制疾病传播和最大限度地减少经济损失至关重要。按测试类型划分，PCR 细分市场在 2023 年占据最大的市场份额，为 45.3%。

PCR 技术的创新也使其更容易用于兽医诊断且更具成本效益，从而推动了其普及。人们越来越认识到约翰氏症对牲畜生产力的影响以及对可靠诊断工具的需求，进一步巩固了 PCR 领域的地位。就动物类型而言，牛细分市场占据主导地位，到2023 年价值将达到5.817 亿美元。量、体重、和整体健康状况。对早期检测的需求支持了该领域诊断的成长。

从地区来看，北美引领约翰病诊断市场，2023 年价值为 2.718 亿美元，预测期内复合年增长率预计为 5.1%。该地区先进的兽医基础设施、生产者意识的提高以及健全的疾病控制监管框架是关键的成长动力。同时，在政府强有力的倡议以及 PCR 和 ELISA 等先进诊断技术的广泛使用的支持下，2023 年美国市场规模为 2.487 亿美元，预计到 2032 年将增至 3.809 亿美元。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 牲畜数量增加
    • 兽医医疗保健支出增加
    • 约翰氏症根除计画和提高对副结核病的认识
  • 产业陷阱与挑战
    • 测试的复杂性和耗时性
    • 疾病的无症状性质
• 成长潜力分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按测试类型，2021 - 2032 年

• 主要趋势
• 酵素连结免疫吸附测定法 (ELISA)
• 聚合酶炼式反应 (PCR)
• 琼脂凝胶免疫扩散 (AGID)

第 6 章：市场估计与预测：按动物类型，2021 - 2032 年

• 主要趋势
• 牛
• 山羊
• 羊
• 其他动物类型

第 7 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 8 章：公司简介

• BioMerieux SA
• Idexx Laboratories, Inc.
• INDICAL BIOSCIENCE GmbH
• Innovative Diagnostics (IDvet)
• MV Diagnostics
• Pictor diagnostics
• Tetracore, Inc.
• Thermo Fisher Scientific Inc.
• VMRD, Inc.
• Zoetis Inc.

The Global Johnes Disease Diagnostics Market, valued at USD 645.6 million in 2023, is projected to expand at a CAGR of 5.2% over the forecast period. This growth is largely attributed to increasing awareness of Johnes disease and its impact on livestock health and productivity. Johnes disease, caused by Mycobacterium avium subspecies paratuberculosis (MAP), is a chronic gastrointestinal infection that affects cattle, sheep, and goats. As livestock producers become more aware of the financial repercussions of this disease, the demand for effective diagnostic solutions is rising.

Recent statistics highlight the widespread prevalence of Johnes disease and its significant economic impact on the livestock industry, underscoring the need for advanced diagnostic methods. Technological advancements in diagnostics, such as PCR and serological tests, have significantly improved the accuracy and speed of detection. These improvements are making diagnostic techniques more appealing to veterinarians and livestock owners. Moreover, the emphasis on animal welfare and sustainable farming practices has further driven the adoption of reliable diagnostic methods to identify and manage infected livestock effectively.

Together, these factors are contributing to the positive growth trajectory of the Johnes disease diagnostics market. Johnes disease diagnostics employ various methods to detect MAP, including the Enzyme-Linked Immunosorbent Assay (ELISA), which identifies antibodies, and the Polymerase Chain Reaction (PCR) test, which detects MAP DNA in fecal samples. Early and accurate diagnosis is critical for controlling disease spread and minimizing economic losses. By test type, the PCR segment held the largest market share at 45.3% in 2023. This segment's growth is driven by its high accuracy, sensitivity, and ability to detect MAP at early stages.

Innovations in PCR technology have also made it more accessible and cost-effective for veterinary diagnostics, which has fueled its popularity. The increasing awareness of Johnes disease's impact on livestock productivity and the demand for reliable diagnostic tools have further strengthened the PCR segment's position. In terms of animal type, the cattle segment dominated the market with a value of USD 581.7 million in 2023. Due to the disease's prevalence in dairy herds, there is a high demand for diagnostic solutions to mitigate the disease's effects on milk production, weight, and overall health. This need for early detection supports the growth of diagnostics in this segment.

Regionally, North America led the Johnes disease diagnostics market, valued at USD 271.8 million in 2023, with an anticipated CAGR of 5.1% during the forecast period. The region's advanced veterinary infrastructure, increased awareness among producers, and robust regulatory frameworks for disease control are key growth drivers. Meanwhile, the U.S. market accounted for USD 248.7 million in 2023, with a projected increase to USD 380.9 million by 2032, supported by strong government initiatives and the widespread use of advanced diagnostics like PCR and ELISA.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing livestock population
    • 3.2.1.2 Rising veterinary healthcare expenditure
    • 3.2.1.3 Johne's disease eradication programs and heightened awareness of paratuberculosis
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Complexity and time-consuming nature of tests
    • 3.2.2.2 Asymptomatic nature of disease
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Enzyme-linked immunosorbent assay (ELISA)
• 5.3 Polymerase chain reaction (PCR)
• 5.4 Agar gel immunodiffusion (AGID)

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Cattle
• 6.3 Goat
• 6.4 Sheep
• 6.5 Other animal types

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
  • 7.3.7 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE
  • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

• 8.1 BioMerieux SA
• 8.2 Idexx Laboratories, Inc.
• 8.3 INDICAL BIOSCIENCE GmbH
• 8.4 Innovative Diagnostics (IDvet)
• 8.5 MV Diagnostics
• 8.6 Pictor diagnostics
• 8.7 Tetracore, Inc.
• 8.8 Thermo Fisher Scientific Inc.
• 8.9 VMRD, Inc.
• 8.10 Zoetis Inc.